USA : Columbia/HCA still seen as solid buy despite probe. NEW YORK 1997-03-31 While shares of Columbia/HCA Healthcare Corp took a beating Monday following a federal probe and media reports about its billing practices , industry analysts continued to support the stock. Link: [Comments: s1 explains which stock the stock in s2 is.] Columbia/HCA lost 4-3/4 to 33 and was the heavily traded issue on the New York Stock Exchange. Chiarelli said he continues to rate the stock as a buy. Columbia/HCA said it was not given the opportunity to review the New York Times' data and could not address the newspaper's findings. Analysts expect Columbia/HCA's stock to continue to face near-term pressure but said the company will remain a market leader over the long-term. _ The stock was in for a tough day today. 